Wednesday August 5, 2020

Oxford Covid-19 vaccine shows promising results

A much larger trial will now get underway

Daniel Murray

Business Reporter

@danieltmurray
20th July, 2020
Work is ongoing around the world on developing a Covid-19 vaccine

A new vaccine for Covid-19 has shown promising results in its initial trial phase.

Produced in the University of Oxford, the vaccine underwent trials on 1,077 people at five different British laboratories. The results of the trials showed that subjects developed antibodies and T-cells capable of fighting off the novel coronavirus.

Antibodies are proteins made by the immune system which protect against viruses, while T-cells are white blood cells that help identify and attack infected cells.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

A new study has revealed this country ranks 19th out of 34 European countries, with patients waiting an average of 521 days

Daniel Murray | 3 days ago

The final phase of the country’s reopening and the approach of winter pose serious challenges to our Covid-19 test-and-trace system

Danielle Barron | 3 days ago

As Spain insists large areas of the country are safe for tourists, does stopping or restricting travel have a material impact on the spread of Covid-19?

Aaron Rogan | 3 days ago